We are evaluating the long-term safety and effectiveness of Galapagos CAR T-cell therapies in patients. This study aims to understand how these treatments work over many years.
Health conditions and diseases that the clinical trial is designed to study and treat.
Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma is a type of cancer that affects the lymphatic system, specifically B-cells, and occurs when the disease returns after treatment or does not respond to initial therapy.
Relapsed/Refractory Multiple Myeloma is a cancer of the plasma cells in the bone marrow that returns after treatment or does not respond to therapy, leading to various complications.
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) is a type of cancer that affects the blood and bone marrow, characterized by the return of the disease after treatment or lack of response to therapy.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
